StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
4
Publishing Date
2024 - 04 - 22
5
2024 - 03 - 25
4
2024 - 03 - 22
5
2024 - 02 - 28
5
2024 - 02 - 15
4
2024 - 02 - 12
4
2023 - 12 - 12
4
2023 - 12 - 05
4
2023 - 09 - 25
4
2023 - 09 - 18
5
2023 - 07 - 27
6
2023 - 07 - 26
6
2023 - 05 - 19
6
2023 - 05 - 15
6
2023 - 04 - 13
5
2023 - 04 - 12
6
2023 - 04 - 11
5
2023 - 02 - 13
5
2023 - 01 - 24
5
2022 - 12 - 06
4
2022 - 11 - 23
4
2022 - 10 - 20
4
2022 - 09 - 29
4
2022 - 09 - 26
4
2022 - 09 - 19
5
2022 - 08 - 17
4
2022 - 08 - 02
4
2022 - 06 - 17
5
2022 - 05 - 16
4
2022 - 04 - 28
7
2022 - 04 - 13
5
2022 - 04 - 12
4
2022 - 03 - 16
4
2022 - 03 - 10
4
2022 - 03 - 08
4
2022 - 03 - 01
5
2022 - 02 - 17
4
2021 - 12 - 14
4
2021 - 11 - 04
4
2021 - 11 - 01
4
2021 - 10 - 29
4
2021 - 09 - 16
4
2021 - 08 - 18
3
2021 - 08 - 11
3
2021 - 08 - 09
3
2021 - 07 - 29
3
2021 - 07 - 23
3
2021 - 07 - 08
4
2021 - 06 - 29
3
2021 - 06 - 11
4
2021 - 06 - 09
5
2021 - 06 - 04
5
2021 - 06 - 03
3
2021 - 05 - 24
4
2021 - 05 - 12
3
2021 - 05 - 10
3
2021 - 04 - 23
3
2021 - 04 - 07
4
2021 - 04 - 05
3
2021 - 04 - 02
3
Sector
Electronic technology
1
Health technology
4
Tags
Alliances
1
Cell carcinoma
1
Contract
1
Ema
1
Fda
1
N/a
2
Phase 3
1
Positive
2
Regulatory
1
Results
2
Therapy
1
Treatment
2
Trial
1
Ulcerative colitis
1
Entities
Abbvie inc.
4
Coherus biosciences, inc.
2
Jabil inc.
1
Thermo fisher scientific inc
1
Symbols
ABB
1
ABBV
4
ABCL
1
ABT
2
ALSMY
2
ALXO
2
AMZN
2
AOMFF
2
ARVL
6
AVGO
2
AVY
3
BGNE
3
BMY
3
BNPQF
2
BNPQY
2
CAT
2
CHRS
2
CPB
2
CRSR
2
DOW
3
ERIC
2
F
2
FNCTF
12
GILD
3
GLT
3
GOOG
2
GOOGL
2
GSFI
2
HRL
3
HUBS
3
IBM
2
IGC
2
JNJ
5
KHC
3
LIFE
2
LLY
3
MG
2
MGNX
2
MMM
3
MS
7
NCNA
2
ORCL
2
PBFX
2
PCSA
2
PHG
3
PLL
2
SAP
2
SNEJF
2
SNOW
2
SNY
2
SO
2
SPWR
2
T
3
TMO
2
TRU
3
UUUU
2
VECT
2
VINC
2
XOM
2
ZLAB
2
Exchanges
Nasdaq
2
Nyse
4
Crawled Date
2021 - 09 - 16
4
Crawled Time
13:00
1
15:15
1
23:00
2
Source
www.biospace.com
2
www.globenewswire.com
1
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 09 - 16
symbols :
ABBV
save search
Coherus and Junshi Biosciences to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06
Published:
2021-09-16
(Crawled : 23:00)
- biospace.com/
ABBV
|
News
|
$167.8
-1.03%
-0.02%
2.9M
|
Health Technology
|
55.7%
|
O:
0.44%
H:
0.47%
C:
-0.15%
CHRS
|
$2.02
-7.34%
-7.39%
630K
|
Health Technology
|
-87.21%
|
O:
-0.7%
H:
2.3%
C:
2.23%
positive
results
Coherus and Junshi Biosciences to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma
Published:
2021-09-16
(Crawled : 23:00)
- globenewswire.com
ABBV
|
News
|
$167.8
-1.03%
-0.02%
2.9M
|
Health Technology
|
55.26%
|
O:
-0.51%
H:
0.0%
C:
0.0%
CHRS
|
$2.02
-7.34%
-7.39%
630K
|
Health Technology
|
-87.4%
|
O:
1.12%
H:
0.0%
C:
0.0%
treatment
positive
therapy
results
phase 3
trial
cell carcinoma
Global $314 Billion Healthcare Contract Development & Manufacturing Organization (CDMO) Market to 2026
Published:
2021-09-16
(Crawled : 15:15)
- prnewswire.com
TMO
|
News
|
$577.39
0.49%
-0.38%
1.7M
|
Health Technology
|
2.56%
|
O:
-0.15%
H:
0.12%
C:
-0.3%
JBL
F
|
$120.24
-0.54%
-1.47%
1.4M
|
Electronic Technology
|
91.4%
|
O:
0.18%
H:
1.1%
C:
0.03%
ABBV
|
News
|
$167.8
-1.03%
-0.02%
2.9M
|
Health Technology
|
55.7%
|
O:
0.44%
H:
0.47%
C:
-0.15%
contract
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
Published:
2021-09-16
(Crawled : 13:00)
- biospace.com/
ABBV
|
News
|
$167.8
-1.03%
-0.02%
2.9M
|
Health Technology
|
55.7%
|
O:
0.44%
H:
0.47%
C:
-0.15%
treatment
fda
ema
ulcerative colitis
Gainers vs Losers
61%
39%
Top 10 Gainers
CSSE
4
|
$0.4253
179.25%
64.77%
210M
|
Consumer Services
BOF
|
$2.08
77.78%
41.21%
110M
|
ILAG
|
$0.54
12.27%
40.62%
3.7M
|
LICN
|
$0.999
78.39%
40.49%
15M
|
AMST
|
$3.4
70.0%
39.58%
70M
|
Technology Services
MTC
|
$3.6
60.71%
38.04%
9.1M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.458
14.5%
30.92%
91K
|
Health Services
WHLM
|
$6.25
35.87%
28.46%
700K
|
Commercial Services
MULN
|
News
|
$3.77
38.1%
27.78%
13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.